Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Joanna R. Groom is active.

Publication


Featured researches published by Joanna R. Groom.


Journal of Clinical Investigation | 2002

Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren’s syndrome

Joanna R. Groom; Susan L. Kalled; Anne H. Cutler; Carl Olson; Stephen A. Woodcock; Pascal Schneider; Jürg Tschopp; Teresa G. Cachero; Marcel Batten; Julie Wheway; Davide Mauri; Dana Cavill; Tom P. Gordon; Charles R. Mackay; Fabienne Mackay

BAFF (BLyS, TALL-1, THANK, zTNF4) is a member of the TNF superfamily that specifically regulates B lymphocyte proliferation and survival. Mice transgenic (Tg) for BAFF develop an autoimmune condition similar to systemic lupus erythematosus. We now demonstrate that BAFF Tg mice, as they age, develop a secondary pathology reminiscent of Sjögrens syndrome (SS), which is manifested by severe sialadenitis, decreased saliva production, and destruction of submaxillary glands. In humans, SS also correlates with elevated levels of circulating BAFF, as well as a dramatic upregulation of BAFF expression in inflamed salivary glands. A likely explanation for disease in BAFF Tg mice is excessive survival signals to autoreactive B cells, possibly as they pass through a critical tolerance checkpoint while maturing in the spleen. The marginal zone (MZ) B cell compartment, one of the enlarged B cell subsets in the spleen of BAFF Tg mice, is a potential reservoir of autoreactive B cells. Interestingly, B cells with an MZ-like phenotype infiltrate the salivary glands of BAFF Tg mice, suggesting that cells of this compartment potentially participate in tissue damage in SS and possibly other autoimmune diseases. We conclude that altered B cell differentiation and tolerance induced by excess BAFF may be central to SS pathogenesis.


Immunology and Cell Biology | 2011

CXCR3 ligands: redundant, collaborative and antagonistic functions

Joanna R. Groom; Andrew D. Luster

CXCR3 is a chemokine receptor that is rapidly induced on naïve T cells following activation, and preferentially remains highly expressed on type‐1 helper (Th1)‐type CD4+ T cells, effector CD8+ T cells and innate‐type lymphocytes, such as natural killer (NK) and NKT cells. CXCR3 is activated by three interferon (IFN)‐γ‐inducible ligands CXCL9 (monokine induced by gamma‐interferon), CXCL10 (interferon‐induced protein‐10) and CXCL11 (interferon‐inducible T‐cell alpha chemoattractant). Although some studies have revealed that these ligands have redundant functions in vivo, other studies have demonstrated that the three CXCR3 ligands can also collaborate and even compete with each other. Differential regulation of the three ligands at specific times in defined anatomically restricted locations in vivo likely participates in the fine control of T‐cell trafficking over the course of an immune response. Among the differences in regulation, CXCL10 is induced by a variety of innate stimuli that induce IFN‐α/β as well as the adaptive immune cell cytokine IFN‐γ, whereas CXCL9 induction is restricted to IFN‐γ. In this review, we will discuss how the balance, timing and pattern of CXCR3 ligand expression appears to regulate the generation of effector T cells in the lymphoid compartment and subsequent migration into peripheral sites of Th1‐type inflammation in which the CXCR3 ligands also then regulate the interactions and migratory behavior of effector T cells in an inflamed peripheral tissue.


Experimental Cell Research | 2011

CXCR3 in T cell function

Joanna R. Groom; Andrew D. Luster

CXCR3 is a chemokine receptor that is highly expressed on effector T cells and plays an important role in T cell trafficking and function. CXCR3 is rapidly induced on naïve cells following activation and preferentially remains highly expressed on Th1-type CD4(+) T cells and effector CD8(+) T cells. CXCR3 is activated by three interferon-inducible ligands CXCL9 (MIG), CXCL10 (IP-10) and CXCL11 (I-TAC). Early studies demonstrated a role for CXCR3 in the trafficking of Th1 and CD8 T cells to peripheral sites of Th1-type inflammation and the establishment of a Th1 amplification loop mediated by IFNγ and the IFNγ-inducible CXCR3 ligands. More recent studies have also suggested that CXCR3 plays a role in the migration of T cells in the microenvironment of the peripheral tissue and lymphoid compartment, facilitating the interaction of T cells with antigen presenting cells leading to the generation of effector and memory cells.


Nature Immunology | 2013

The transcription factor T-bet is essential for the development of NKp46+ innate lymphocytes via the Notch pathway

Lucille C. Rankin; Joanna R. Groom; Michaël Chopin; Marco J. Herold; Jennifer Walker; Lisa A. Mielke; Andrew N. J. McKenzie; Sebastian Carotta; Stephen L. Nutt; Gabrielle T. Belz

NKp46+ innate lymphoid cells (ILCs) serve important roles in regulating the intestinal microbiota and defense against pathogens. Whether NKp46+ ILCs arise directly from lymphoid tissue–inducer (LTi) cells or represent a separate lineage remains controversial. We report here that the transcription factor T-bet (encoded by Tbx21) was essential for the development of NKp46+ ILCs but not of LTi cells or nuocytes. Deficiency in interleukin 22 (IL-22)-producing NKp46+ ILCs resulted in greater susceptibility of Tbx21−/− mice to intestinal infection. Haploinsufficient T-bet expression resulted in lower expression of the signaling molecule Notch, and Notch signaling was necessary for the transition of LTi cells into NKp46+ ILCs. Furthermore, NKp46+ ILCs differentiated solely from the CD4− LTi population, not the CD4+ LTi population. Our results pinpoint the regulation of Notch signaling by T-bet as a distinct molecular pathway that guides the development of NKp46+ ILCs.


Journal of Experimental Medicine | 2013

Retinoic acid expression associates with enhanced IL-22 production by γδ T cells and innate lymphoid cells and attenuation of intestinal inflammation

Lisa A Mielke; Sarah A. Jones; Mathilde Raverdeau; Rowan Higgs; Anna M. Stefanska; Joanna R. Groom; Alicja Misiak; Lara S. Dungan; Caroline E. Sutton; Gundula Streubel; Adrian P. Bracken; Kingston H. G. Mills

Retinoic acid attenuates colitis and is associated with increased IL-22 production from γδ T cells and innate lymphoid cells and enhanced antimicrobial peptide expression.


Journal of Experimental Medicine | 2014

Nfil3 is required for the development of all innate lymphoid cell subsets

Cyril Seillet; Lucille C. Rankin; Joanna R. Groom; Lisa A. Mielke; Julie Tellier; Michaël Chopin; Nicholas D. Huntington; Gabrielle T. Belz; Sebastian Carotta

Loss of Nfil3 selectively reduces Peyer’s patch formation, impairing recruitment and distribution of lymphocytes and compromising immune responses to inflammatory and infectious agents.


Journal of Immunology | 2013

TCF-1 Controls ILC2 and NKp46+RORγt+ Innate Lymphocyte Differentiation and Protection in Intestinal Inflammation

Lisa A. Mielke; Joanna R. Groom; Lucille C. Rankin; Cyril Seillet; Frederick Masson; Tracy Putoczki; Gabrielle T. Belz

Innate lymphocyte populations play a central role in conferring protective immunity at the mucosal frontier. In this study, we demonstrate that T cell factor 1 (TCF-1; encoded by Tcf7), a transcription factor also important for NK and T cell differentiation, is expressed by multiple innate lymphoid cell (ILC) subsets, including GATA3+ nuocytes (ILC2) and NKp46+ ILCs (ILC3), which confer protection against lung and intestinal inflammation. TCF-1 was intrinsically required for the differentiation of both ILC2 and NKp46+ ILC3. Loss of TCF-1 expression impaired the capacity of these ILC subsets to produce IL-5, IL-13, and IL-22 and resulted in crippled responses to intestinal infection with Citrobacter rodentium. Furthermore, a reduction in T-bet expression required for Notch-2–dependent development of NKp46+ ILC3 showed a dose-dependent reduction in TCF-1 expression. Collectively, our findings demonstrate an essential requirement for TCF-1 in ILC2 differentiation and reveal a link among Tcf7, Notch, and Tbx21 in NKp46+ ILC3 development.


Molecular and Cellular Biology | 2002

The Absence of Tssc6, a Member of the Tetraspanin Superfamily, Does Not Affect Lymphoid Development but Enhances In Vitro T-Cell Proliferative Responses

Jacqueline M. Tarrant; Joanna R. Groom; Donald Metcalf; Ruili Li; Bette Borobokas; Mark D. Wright; David M. Tarlinton; Lorraine Robb

ABSTRACT The tetraspanins are a family of integral membrane proteins with four transmembrane domains. These molecules form multimolecular networks on the surfaces of many different cell types. Gene-targeting studies have revealed a role for tetraspanins in B- and T-lymphocyte function. We have isolated and deleted a novel tetraspanin, Tssc6, which is expressed exclusively in hematopoietic and lymphoid organs. Using a gene-trapping strategy, we generated an embryonic stem (ES) cell line with an insertion in the Tssc6 locus. Mice were derived from these ES cells and, using RNase protection and reverse transcription-PCR, we demonstrated that the insertion resulted in a null mutation of the Tssc6 allele. Mice homozygous for the gene trap insertion (Tssc6gt/gt mice) were viable and fertile, with normal steady-state hematopoiesis. Furthermore, responses to hemolysis and granulocyte colony-stimulating factor-induced granulopoiesis were equivalent to those of wild-type mice. Lymphoid development was normal in Tssc6gt/gt mice. Whereas Tssc6gt/gt B cells responded normally to lipopolysaccharide, anti-CD40, and anti-immunoglobulin M stimulation, Tssc6gt/gt T cells showed enhanced responses to concanavalin A, anti-CD3, and anti-CD28. This increased proliferation by Tssc6-deleted T lymphocytes was due to increased interleukin 2 production following T-cell receptor stimulation. These results demonstrate that Tssc6 is not required for normal development of the hematopoietic system but may play a role in the negative regulation of peripheral T-lymphocyte proliferation.


Current Opinion in Rheumatology | 2007

An important role for B-cell activation factor and B cells in the pathogenesis of Sjögren's syndrome

Fabienne Mackay; Joanna R. Groom; Stuart G. Tangye

Purpose of reviewThis review provides an update on the specific, strong association between dysregulated production of the cytokine B-cell activation factor and Sjögrens syndrome, and offers new perspectives on potential pathogenic mechanisms. Recent findingsExcess B-cell activation factor in mice triggers Sjögrens syndrome-like symptoms, and elevated serum B-cell activation factor in humans correlates with Sjögrens syndrome. B-cell activation factor is produced locally by activated monocytes, T cells and dendritic cells, and by epithelial cells and infiltrating B cells. Moreover, recent data in humans suggest that the innate immune system plays a role as an initiator of immune disorders in inflamed tissues. SummaryRecent data have demonstrated the critical role of B-cell activation factor and B cells in the pathogenesis of Sjögrens syndrome, and its association with B lymphomas. Moreover, B-cell depleting treatments have confirmed the critical role of B cells in Sjögrens syndrome. Excess B-cell activation factor possibly corrupts B-cell tolerance and allows the emergence of self-reactive B cells that efficiently present antigen to T cells. In addition, B-cell activation factor may stimulate T-cell independent activation of B cells via Toll-like receptors; this recently identified mechanism could also play a separate, detrimental role in autoimmunity.


Journal of Experimental Medicine | 2014

Trans-nodal migration of resident dendritic cells into medullary interfollicular regions initiates immunity to influenza vaccine

Matthew Woodruff; Balthasar A. Heesters; Caroline N. Herndon; Joanna R. Groom; Paul G. Thomas; Andrew D. Luster; Shannon J. Turley; Michael C. Carroll

Resident lymph node DCs rapidly locate viral influenza antigen to drive early activation of T cells, resulting in germinal center formation and B cell memory.

Collaboration


Dive into the Joanna R. Groom's collaboration.

Top Co-Authors

Avatar

Gabrielle T. Belz

Walter and Eliza Hall Institute of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Lisa A. Mielke

Walter and Eliza Hall Institute of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Lucille C. Rankin

Walter and Eliza Hall Institute of Medical Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Cyril Seillet

Walter and Eliza Hall Institute of Medical Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Fanny Lafouresse

Walter and Eliza Hall Institute of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Michaël Chopin

Walter and Eliza Hall Institute of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Sebastian Carotta

Walter and Eliza Hall Institute of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Stephen L. Nutt

Walter and Eliza Hall Institute of Medical Research

View shared research outputs
Researchain Logo
Decentralizing Knowledge